Global Nonalcoholic Steatohepatitis Therapeutics Market Report 2023 Featuring Pfizer, Inventiva, - Benzinga

GLMD Stock  USD 2.82  0.06  2.08%   
About 57% of Galmed Pharmaceuticals' investor base is looking to short. The analysis of the overall investor sentiment regarding Galmed Pharmaceuticals suggests that many traders are alarmed. The current market sentiment, together with Galmed Pharmaceuticals' historical and current headlines, can help investors time the market. In addition, many technical investors use Galmed Pharmaceuticals stock news signals to limit their universe of possible portfolio assets.
  
Global Nonalcoholic Steatohepatitis Therapeutics Market Report 2023 Featuring Pfizer, Inventiva, Benzinga

Read at news.google.com
Google News at Macroaxis
  

Galmed Pharmaceuticals Fundamental Analysis

We analyze Galmed Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Galmed Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Galmed Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Number Of Shares Shorted

Number Of Shares Shorted Comparative Analysis

Galmed Pharmaceuticals is currently under evaluation in number of shares shorted category among its peers. Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up.

Galmed Pharmaceuticals Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Galmed Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Galmed Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Galmed Pharmaceuticals by comparing valuation metrics with similar companies.

Peers

Galmed Pharmaceuticals Related Equities

APTOAptose Biosciences   5.56   
0%
64.0%
MBIOMustang Bio   5.26   
0%
60.0%
LPTXLeap Therapeutics   4.43   
0%
51.0%
ADAPAdaptimmune Therapeutics   3.23   
0%
37.0%
FBIOPFortress Biotech   0.29   
0%
3.0%
ABEOAbeona Therapeutics   1.66   
19.0%
0%
PIRSPieris Pharmaceuticals   2.35   
27.0%
0%
ACHLAchilles Therapeutics   2.86   
33.0%
0%
MREOMereo BioPharma   3.12   
36.0%
0%
FBIOFortress Biotech   3.40   
39.0%
0%
ADVMAdverum Biotechnologies   3.54   
40.0%
0%
AFMDAffimed NV   3.54   
40.0%
0%
AKBAAkebia Ther   5.21   
60.0%
0%
KODKodiak Sciences   6.38   
73.0%
0%
PDSBPDS Biotechnology   8.65   
100.0%
0%

Complementary Tools for Galmed Stock analysis

When running Galmed Pharmaceuticals' price analysis, check to measure Galmed Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Galmed Pharmaceuticals is operating at the current time. Most of Galmed Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Galmed Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Galmed Pharmaceuticals' price. Additionally, you may evaluate how the addition of Galmed Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Money Managers
Screen money managers from public funds and ETFs managed around the world
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes